Belle Capital

TO THE MARKET specializes in the ethical manufacturing and sourcing of apparel, accessories, and home goods. Established in 2016 and based in the United States, the company collaborates with artisan groups and suppliers globally to provide sustainable solutions. Its services encompass design, production, compliance, sourcing, logistics, and reporting, catering to a diverse clientele, including Fortune 500 companies, brands, and retailers. By focusing on transparency, sustainability, and authenticity, TO THE MARKET aims to create products that resonate with a new generation of consumers, while promoting a supply chain that empowers communities and protects the environment.

TO THE MARKET specializes in the ethical manufacturing and sourcing of apparel, accessories, and home goods. Established in 2016 and based in the United States, the company collaborates with artisan groups and suppliers globally to provide sustainable solutions. Its services encompass design, production, compliance, sourcing, logistics, and reporting, catering to a diverse clientele, including Fortune 500 companies, brands, and retailers. By focusing on transparency, sustainability, and authenticity, TO THE MARKET aims to create products that resonate with a new generation of consumers, while promoting a supply chain that empowers communities and protects the environment.

Ocuphire Pharma is a clinical-stage biopharmaceutical company focuses on the development and commercialization of therapies to treat patients with a variety of ophthalmic disorders. It is currently focused on providing a novel once-daily eye drop treatment option, Nyxol, to treat multiple front-of-the-eye disorders, including night vision disturbances, glaucoma, pharmacologically-induced mydriasis, and presbyopia. Nyxol eye drops are an investigational 505(b)(2) drug candidate in late-stage clinical development with over a decade of safety and efficacy data from Phase 1 and 2 trials. Part of their strategy is to explore opportunities to acquire additional ophthalmic assets for both the front and the back of the eyes and to seek strategic partners for global commercialization. The company was founded in 2018 and is headquartered in Farmington Hills, Michigan.

Vital Vio offers a new class of antimicrobial light for infection and germ control through safe, continuous LED products. Our goal is to protect as many people and places from germs as possible with our products which can be utilized anywhere a light can fit. We service customers in food processing, healthcare, industrial/commercial as well as a licensing model for consumer and residential products.

Joylux is a health and wellness company that specializes in women's health and wellness. The company is committed to finding scientific solutions that are noninvasive, effective, and affordable to help improve all aspects of a woman’s intimate life. The company was founded in 2013 and headquartered in Seattle, Washington.

Digsite® is a SaaS platform for social-media style market research that allows users to quickly engage consumers to build and optimize early ideas for new product concepts, marketing programs, or customer experiences. Marketers, researchers and agencies use Digsite to learn and iterate with consumers over 24 hours or more. The result is better, faster business decisions. Digsite is at the forefront of qualitative market research automation, making it possible to recruit, set-up and launch a social-media style research community with up to 100 consumers in one day or less. The platform looks and feels familiar – like the social media sites people use everyday on their smart phones, tablets and computers. However, Digsite offers a turn-key interface and advanced automation to make it fast and easy to identify and recruit participants, create a community with expert-designed activities, manage participation & rewards, and download summary reporting. It also embeds proprietary research-specific tools to manage conversations, build surveys, mark-up images, capture video and more.

CardiaLen develops and commercializes pain-free cardioversion therapies for atrial fibrillation. The company is developing implantable low-energy (low voltage) pain-free atrial cardioverters to help address the major unmet needs of this condition. It was founded in 2008 and headquartered in Minneapolis, Minnesota.

Current Motor fills the unmet need for fast, fun, affordable, zero-emission, electric vehicles (EVs). Current Motor develops and manufactures all-electric maxi-scooters for the Americas, made in Michigan. The company’s EVs use no gas, produce no emissions and create no maintenance hassles. Their maxi-scooters offer speeds up to 70 MPH and a range of up to 50 miles. They charge from a standard 110V household outlet in 5 hours. Backed by BELLE Capital, the State of Michigan and other private equity investors, please visit www.currentmotor.com for more information. They are shipping Test Pilot (beta) bikes with full production maxi-scooters scheduled to ship at the end of the 2011.